4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010507
CHIEF COMMERCIAL OFFICER gave up 1,353 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 2,477 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-08 | Option exercise | +2,477 | 17,629 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-08 | Shares withheld for taxes | −1,353 | $17.90 | $24,219 | 16,276 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-04 | Grant or award · Share Option | +36,100 | 36,100 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-04 | Grant or award · Performance Share Unit | +5,569 | 5,569 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-04 | Grant or award · Restricted Share Unit | +6,962 | 11,795 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-08 | Option exercise · Restricted Share Unit | −2,477 | 9,318 | D | ||
Loading xslF345X05/form4-04082024_090417.xml…